Gutierrez-Ramos Jose-Carlos
Officer at DHR; Director at MOMENTA PHARMACEUTICALS INC
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Aug 21, 2023
- Form 144 notices
- 2
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- DHRDANAHER CORP /DE/Officer
- MOMENTA PHARMACEUTICALS INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MOMENTA PHARMACEUTICALS INC20,090 shares
- DHR1,090 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MOMENTA PHARMACEUTICALS INCUnusualJan 21 2020
Sold 10,090 shares at $29.10 ($294k)
Gutierrez-Ramos Jose-Carlos, Director
Sold 100% of holdings ($294k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale MOMENTA PHARMACEUTICALS INCUnusualAug 19 +211 days
Sold 10,000 shares at $52.09 ($521k)
Gutierrez-Ramos Jose-Carlos, Director
Sold 100% of holdings ($521k position)0 shares leftFiling
- 3 Form 144 notice DHRNoticeMay 1 +985 days
Filed to sell 500 shares ($121k)
Gutierrez-Ramos Jose-Carlos, Officer
No 10b5-1 planFirst sale on recordFiling
- 4 Form 4 sale DHRNo planMay 1 same day
Sold 500 shares at $242.19 ($121k)
Gutierrez-Ramos Jose-Carlos, SVP, Chief Science Officer
No 10b5-1 planSold 6.2% of holdings ($1.9M position)7,529 shares leftFirst sale on recordFollows a Form 144Filing
- 5 Form 144 notice DHRNoticeAug 21 +112 days
Filed to sell 590 shares ($148k)
Gutierrez-Ramos Jose-Carlos, Officer
No 10b5-1 planFiling
- 6 Form 4 sale DHRNo planAug 21 same day
Sold 590 shares at $250.54 ($148k)
Gutierrez-Ramos Jose-Carlos, SVP, Chief Science Officer
No 10b5-1 planSold 7.8% of holdings ($1.9M position)6,939 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (6)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2023 | DHR | SVP, Chief Science Officer | Form 4 sale | 590 | $148k | 7.8% | No plan | SEC |
| Aug 21, 2023 | DHR | Officer | Form 144 notice | 590 | $148k | Notice | SEC | |
| May 1, 2023 | DHR | SVP, Chief Science Officer | Form 4 sale | 500 | $121k | 6.2% | No plan | SEC |
| May 1, 2023 | DHR | Officer | Form 144 notice | 500 | $121k | Notice | SEC | |
| Aug 19, 2020 | MOMENTA PHARMACEUTICALS INC | Director | Form 4 sale | 10,000 | $521k | 100.0% | Unusual | SEC |
| Jan 21, 2020 | MOMENTA PHARMACEUTICALS INC | Director | Form 4 sale | 10,090 | $294k | 100.0% | Unusual | SEC |